{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:11:34Z","timestamp":1790187094490,"version":"4.1.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["R01AI123272"],"award-info":[{"award-number":["R01AI123272"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007800","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T13:30:30Z","timestamp":1573738230000},"page":"e0007800","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses"],"prefix":"10.1371","volume":"13","author":[{"given":"Joseph R.","family":"Plummer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-070X","authenticated-orcid":true,"given":"James P.","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"issue":"7","key":"pntd.0007800.ref001","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"SA Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"pntd.0007800.ref002","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1586\/erv.10.105","article-title":"Experimental rabies vaccines for humans","volume":"9","author":"JP McGettigan","year":"2010","journal-title":"Expert Review of Vaccines"},{"key":"pntd.0007800.ref003","volume-title":"Rabies","author":"AC Jackson","year":"2007"},{"key":"pntd.0007800.ref004","first-page":"869718","article-title":"Targeting antigens to dendritic cell receptors for vaccine development","volume":"2013","author":"V Apostolopoulos","year":"2013","journal-title":"JDrug Deliv"},{"issue":"2","key":"pntd.0007800.ref005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.it.2011.10.007","article-title":"Boosting antibody responses by targeting antigens to dendritic cells","volume":"33","author":"I Caminschi","year":"2012","journal-title":"Trends Immunol"},{"issue":"2","key":"pntd.0007800.ref006","first-page":"259","article-title":"New generation of dendritic cell vaccines","volume":"9","author":"KJ Radford","year":"2013","journal-title":"HumVaccin Immunother"},{"issue":"2","key":"pntd.0007800.ref007","first-page":"61","article-title":"Improving vaccines by targeting antigens to dendritic cells","volume":"41","author":"K Shortman","year":"2009","journal-title":"ExpMolMed"},{"issue":"10","key":"pntd.0007800.ref008","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1084\/jem.20130188","article-title":"Targeting antigens to CD180 rapidly induces antigen-specific IgG, affinity maturation, and immunological memory","volume":"210","author":"JW Chaplin","year":"2013","journal-title":"JExpMed"},{"issue":"1\u20133","key":"pntd.0007800.ref009","first-page":"197","article-title":"Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity","volume":"36","author":"FR Toapanta","year":"2006","journal-title":"ImmunolRes"},{"key":"pntd.0007800.ref010","first-page":"249","article-title":"A minimum CR2 binding domain of C3d enhances immunity following vaccination","volume":"586","author":"JF Bower","year":"2006","journal-title":"AdvExpMedBiol"},{"issue":"2","key":"pntd.0007800.ref011","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1570162053506937","article-title":"C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences","volume":"3","author":"JF Bower","year":"2005","journal-title":"Current HIV research"},{"issue":"9","key":"pntd.0007800.ref012","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1128\/JVI.78.9.4710-4719.2004","article-title":"Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d","volume":"78","author":"JF Bower","year":"2004","journal-title":"Journal of virology"},{"issue":"4","key":"pntd.0007800.ref013","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1128\/JVI.78.4.1616-1622.2004","article-title":"Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus","volume":"78","author":"L Wang","year":"2004","journal-title":"Journal of virology"},{"issue":"14","key":"pntd.0007800.ref014","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3748\/wjg.v10.i14.2072","article-title":"Contribution of C3d-P28 repeats to enhancement of immune responses against HBV-preS2\/S induced by gene immunization","volume":"10","author":"LX Wang","year":"2004","journal-title":"World JGastroenterol"},{"key":"pntd.0007800.ref015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1743-422X-7-95","article-title":"Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice","volume":"7","author":"MD Dunn","year":"2010","journal-title":"VirolJ"},{"issue":"5","key":"pntd.0007800.ref016","first-page":"3031","article-title":"Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide","volume":"69","author":"ST Test","year":"2001","journal-title":"InfectImmun"},{"issue":"5247","key":"pntd.0007800.ref017","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"PW Dempsey","year":"1996","journal-title":"Science"},{"key":"pntd.0007800.ref018","article-title":"Lymph node but not intradermal injection site macrophages are critical for germinal center formation and antibody responses to rabies vaccination","author":"AG Lytle","year":"2014","journal-title":"Journal of virology"},{"issue":"16","key":"pntd.0007800.ref019","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1128\/JVI.00800-13","article-title":"B Cell Infection and Activation by Rabies Virus-Based Vaccines","volume":"87","author":"AG Lytle","year":"2013","journal-title":"Journal of virology"},{"issue":"1","key":"pntd.0007800.ref020","doi-asserted-by":"crossref","first-page":"e87098","DOI":"10.1371\/journal.pone.0087098","article-title":"ICAM-1-Based Rabies Virus Vaccine Shows Increased Infection and Activation of Primary Murine B Cells In Vitro and Enhanced Antibody Titers In-Vivo","volume":"9","author":"JE Norton","year":"2014","journal-title":"PLoS ONE"},{"issue":"7","key":"pntd.0007800.ref021","first-page":"491","article-title":"Cracking the BAFF code","volume":"9","author":"F Mackay","year":"2009","journal-title":"NatRevImmunol"},{"issue":"1","key":"pntd.0007800.ref022","first-page":"115","article-title":"Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease","volume":"244","author":"RC Rickert","year":"2011","journal-title":"ImmunolRev"},{"issue":"10","key":"pntd.0007800.ref023","first-page":"3954","article-title":"Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI","volume":"121","author":"AI Wolf","year":"2011","journal-title":"JClinInvest"},{"issue":"9","key":"pntd.0007800.ref024","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.vaccine.2008.12.040","article-title":"BAFF enhances B-cell-mediated immune response and vaccine-protection against a very virulent IBDV in chickens","volume":"27","author":"L Chen","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"pntd.0007800.ref025","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.4049\/jimmunol.1200466","article-title":"BLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses","volume":"188","author":"P Dosenovic","year":"2012","journal-title":"JImmunol"},{"key":"pntd.0007800.ref026","first-page":"9","article-title":"Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS).","volume":"6","author":"DO Gor","year":"2011","journal-title":"BiolDirect"},{"issue":"2","key":"pntd.0007800.ref027","doi-asserted-by":"crossref","first-page":"e90100","DOI":"10.1371\/journal.pone.0090100","article-title":"HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity","volume":"9","author":"S Kanagavelu","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"pntd.0007800.ref028","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.vaccine.2011.11.088","article-title":"Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine","volume":"30","author":"SK Kanagavelu","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"pntd.0007800.ref029","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1371\/journal.pntd.0000679","article-title":"BAFF mediates splenic B cell response and antibody production in experimental Chagas disease","volume":"4","author":"DA Bermejo","year":"2010","journal-title":"PLoS Negl TropDis"},{"key":"pntd.0007800.ref030","article-title":"Recruitment and Retention of B Cells in the Cns in Response to Alphavirus Encephalomyelitis","author":"TU Metcalf","year":"2012","journal-title":"Journal of virology"},{"key":"pntd.0007800.ref031","article-title":"Targeting Vaccine-induced Extrafollicular Pathway of B cell Differentiation Improves Rabies Post-exposure Porphylaxix","author":"SL Haley","year":"2017","journal-title":"J Virol"},{"key":"pntd.0007800.ref032","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2017.06.004","article-title":"APRIL:TACI axis is dispensable for the immune response to rabies vaccination","author":"SL Haley","year":"2017"},{"issue":"2","key":"pntd.0007800.ref033","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(90)90433-R","article-title":"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19","volume":"175","author":"KK Conzelmann","year":"1990","journal-title":"Virology"},{"issue":"1","key":"pntd.0007800.ref034","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"JP McGettigan","year":"2003","journal-title":"Journal of Virology"},{"issue":"7","key":"pntd.0007800.ref035","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1073\/pnas.97.7.3544","article-title":"Recombinant rabies virus as potential live-viral vaccines for HIV-1","volume":"97","author":"MJ Schnell","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"pntd.0007800.ref036","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/605949","article-title":"Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates","volume":"200","author":"J Cenna","year":"2009","journal-title":"JInfectDis"},{"issue":"50","key":"pntd.0007800.ref037","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1016\/j.vaccine.2008.08.069","article-title":"Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene","volume":"26","author":"J Cenna","year":"2008","journal-title":"Vaccine"},{"issue":"21","key":"pntd.0007800.ref038","doi-asserted-by":"crossref","first-page":"11533","DOI":"10.1128\/JVI.00615-12","article-title":"Protective Vaccine-Induced CD4+ T Cell-Independent B Cell Responses against Rabies Infection","volume":"86","author":"CL Dorfmeier","year":"2012","journal-title":"Journal of virology"},{"issue":"16","key":"pntd.0007800.ref039","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1128\/JVI.00995-13","article-title":"Reinvestigating the role of IgM in rabies virus post-exposure vaccination","volume":"87","author":"CL Dorfmeier","year":"2013","journal-title":"Journal of virology"},{"issue":"3","key":"pntd.0007800.ref040","first-page":"e2129","article-title":"Investigating the Role for IL-21","volume":"7","author":"CL Dorfmeier","year":"2013","journal-title":"Rabies Virus Vaccine-induced Immunity. PLoS Negl TropDis"},{"issue":"5","key":"pntd.0007800.ref041","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1128\/JVI.03409-14","article-title":"Lymph node but not intradermal injection site macrophages are critical for germinal center formation and antibody responses to rabies vaccination","volume":"89","author":"AG Lytle","year":"2015","journal-title":"Journal of virology"},{"issue":"2","key":"pntd.0007800.ref042","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.virol.2006.05.010","article-title":"Rabies virus glycoprotein as a carrier for anthrax protective antigen","volume":"353","author":"ME Smith","year":"2006","journal-title":"Virology"},{"issue":"11","key":"pntd.0007800.ref043","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"P Schneider","year":"1999","journal-title":"JExpMed"},{"key":"pntd.0007800.ref044","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M116.725929","article-title":"Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell Hyperplasia","author":"C Kowalczyk-Quintas","year":"2016"},{"issue":"37","key":"pntd.0007800.ref045","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.vaccine.2018.06.061","article-title":"Rabies vaccines: WHO position paper, April 2018\u2014Recommendations.","volume":"36","author":"World Health O","year":"2018","journal-title":"Vaccine"},{"key":"pntd.0007800.ref046","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"CE Rupprecht","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"pntd.0007800.ref047","first-page":"139","article-title":"Intradermal rabies vaccination: the evolution and future of pre- and post-exposure prophylaxis","volume":"351","author":"MJ Warrell","year":"2012","journal-title":"CurrTopMicrobiolImmunol"},{"issue":"3","key":"pntd.0007800.ref048","first-page":"755","article-title":"Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis","volume":"99","author":"P Suntharasamai","year":"1987","journal-title":"EpidemiolInfect"},{"issue":"2","key":"pntd.0007800.ref049","first-page":"208","article-title":"Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial","volume":"93","author":"J Lang","year":"1999","journal-title":"TransRSocTropMedHyg"},{"issue":"11\u201312","key":"pntd.0007800.ref050","first-page":"541","article-title":"The path to a successful vaccine adjuvant\u2014'the long and winding road'","volume":"14","author":"DT O'Hagan","year":"2009","journal-title":"Drug DiscovToday"},{"issue":"9","key":"pntd.0007800.ref051","doi-asserted-by":"crossref","first-page":"e515","DOI":"10.1371\/journal.pntd.0000515","article-title":"Novel vaccines to human rabies","volume":"3","author":"HC Ertl","year":"2009","journal-title":"PLoS Neglected Tropical Diseases [electronic resource]."},{"issue":"15","key":"pntd.0007800.ref052","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.vaccine.2008.01.043","article-title":"A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine","volume":"26","author":"X Wang","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"pntd.0007800.ref053","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3390\/v7031134","article-title":"Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus","volume":"7","author":"H Kang","year":"2015","journal-title":"Viruses"},{"issue":"20","key":"pntd.0007800.ref054","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.00558-11","article-title":"Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses","volume":"85","author":"JE Blaney","year":"2011","journal-title":"Journal of virology"},{"key":"pntd.0007800.ref055","first-page":"169","article-title":"Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs","volume":"6","author":"Y Qi","year":"2015","journal-title":"Front Microbiol"},{"issue":"4","key":"pntd.0007800.ref056","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/v8040115","article-title":"Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus","volume":"8","author":"X Ji","year":"2016","journal-title":"Viruses"},{"issue":"40","key":"pntd.0007800.ref057","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1016\/j.vaccine.2018.08.053","article-title":"Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice","volume":"36","author":"Z Ren","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"pntd.0007800.ref058","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1586\/erv.12.70","article-title":"Virus-like particles as universal influenza vaccines","volume":"11","author":"SM Kang","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"pntd.0007800.ref059","article-title":"Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA\/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs Enhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant","author":"X Sun","year":"2017"},{"key":"pntd.0007800.ref060","doi-asserted-by":"crossref","first-page":"11856","DOI":"10.1038\/srep11856","article-title":"Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs","volume":"5","author":"H Feng","year":"2015","journal-title":"Scientific reports"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T13:30:52Z","timestamp":1573738252000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007800"}},"subtitle":[],"editor":[{"given":"Sergio","family":"Recuenco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007800","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]}}}